Genetic diversity of natural populations of Trypanosoma cruzi in clinical samples from patients with oral Chagas disease in Venezuela: Follow-up after treatment with trypanocidal drugs

dc.creatorMuñoz Calderon, Arturo Alejandro
dc.creatorDíaz Bello, Zoraida
dc.creatorAlarcón de Noya, Belkisyolé
dc.creatorSchijman, Alejandro Gabriel
dc.date2019
dc.date.accessioned2023-08-31T00:08:47Z
dc.date.available2023-08-31T00:08:47Z
dc.identifierhttp://hdl.handle.net/11336/202025
dc.identifierGenetic diversity of natural populations of Trypanosoma cruzi in clinical samples from patients with oral Chagas disease in Venezuela: Follow-up after treatment with trypanocidal drugs; Reunión Anual de Sociedades de Biociencia 2019; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas; VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2019; 123-123
dc.identifier0025-7680
dc.identifier1669-9106
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8543148
dc.descriptionOral transmission of Chagas disease (OChD) is an increasingly important aspect in the epidemiology. Venezuela has reported the two largest outbreaks described so far, affecting a total of 192 people mostly children. The long-term impact after treatment on the dynamics of infection in natural populations of T. cruzi is still unclear. In this sense, we proposed a genetic characterization of T. cruzi populations present in peripheral blood in order to differentiate responder or non-responder patients and predict the response to treatment (Tmt). We performed quantification of the parasitic load by qPCR, genetic typing of T. cruzi populations by multiplex qPCR of nuclear genome markers and RFLP-PCR for the hypervariable region of T. cruzi kDNA to demonstrate changes in Minicircle signatures (Ms) of the parasite populations present in 41 clinical samples from 15 patients. To reflect the genetic diversity found, Jaccard distances (Jd) values were compared. This clinical monitoring confirmed the presence of T. cruzi DNA in 26 post-treatment samples up to 9 years after Tmt. These results reveal 100 % therapeutic failure for both outbreaks of OChD, classifying these patients as non-responders to Tmt. All samples showed homogeneity at the DTU level, being typified as TcI. The Ms showed a high degree of polymorphism, with 73 % of total post-Tmt samples with Jd values close to 1. Analyzing the dynamics of each patient`s population separately, in all post-Tmt samples the change in Ms variability respect to pre-Tmt sample was not statistically significant. This variability does not reflect a natural or induced clonal selection process driven by the etiological Tmt; on the contrary, it could be associated with the clonal histotropism process evidenced in natural T. cruzi infections. In conclusion, these strategies of molecular characterization of parasite DNA were useful to detect Tmt failure and find out the lack of parasite population selection with Tmt in these OChD settings.
dc.descriptionFil: Muñoz Calderon, Arturo Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
dc.descriptionFil: Díaz Bello, Zoraida. Instituto de Medicina Tropical "Dr. Felix Pifano"; Venezuela
dc.descriptionFil: Alarcón de Noya, Belkisyolé. Instituto de Medicina Tropical "Dr. Felix Pifano"; Venezuela
dc.descriptionFil: Schijman, Alejandro Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
dc.descriptionReunión Anual de Sociedades de Biociencia 2019; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas; VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
dc.descriptionMar del Plata
dc.descriptionArgentina
dc.descriptionSociedad Argentina de Investigación Clínica
dc.descriptionAsociación Argentina de Farmacología Experimenta
dc.descriptionSociedad Argentina de Biología
dc.descriptionSociedad Argentina de Protozoología
dc.descriptionAsociación Argentina de Nanomedicinas
dc.descriptionAsociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherMedicina (Buenos Aires)
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://medicinabuenosaires.com/revistas/vol79-19/s4/vol79_s4.pdf
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subjectTrypanosoma cruzi
dc.subjectOral Chagas disease
dc.subjectTreatment
dc.subjectFollow up
dc.subjecthttps://purl.org/becyt/ford/3.3
dc.subjecthttps://purl.org/becyt/ford/3
dc.titleGenetic diversity of natural populations of Trypanosoma cruzi in clinical samples from patients with oral Chagas disease in Venezuela: Follow-up after treatment with trypanocidal drugs
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeinfo:eu-repo/semantics/conferenceObject
dc.typeinfo:ar-repo/semantics/documento de conferencia
dc.typeReunión
dc.typeJournal
dc.coverageInternacional


Este ítem pertenece a la siguiente institución